Skip to main content

Table 6 Percent of time spent in each functional state over 48-h

From: Reduction of pain and functional disability over time in patients treated with zavegepant: a post-hoc analysis of the BHV3500-301 phase 3 randomized controlled trial

 

Complete case analysis

Functional states

Zav (n = 328)

PBO (n = 313)

Mean difference

Normal

82%

76%

 + 6

Mildly impaired

14%

18%

 − 4

Severely impaired

2%

4%

 − 2

Requires bedrest

2%

1%

 + 1

 

MNAR imputation analysis

Functional states

Zav (n = 623)

PBO (n = 646)

Mean difference

Normal

66%

59%

 + 7

Mildly impaired

26%

31%

 − 5

Severely impaired

5%

7%

 − 2

Requires bedrest

3%

3%

0

  1. Abbreviations: MNA missing not at random PBO placebo, zav zavegepant